Tirzepatide, the drug in Mounjaro, is a long-acting medication thats started at a lower dose to reduce the number and severity of side effects as its built up to a higher maintenance dose
Read Detailed Aerticle of Pharma News Weekly on - Pharma News Weekly India Disclaimer and References This article is compiled for informational purposes based on publicly available pharmaceutical industry updates, market reports, and news sources including Economic Times, Business Line, Financial Express, Mint, Pharmarack data, and global pharma publications
Not Adjusting Based on Results The goal of a protocol is results
Losing muscle along with fat sabotages your metabolism and leaves you weaker, not healthier
[42]) principally regulates glucagon secretion by paracrine mechanisms [54] resulting from activation of the GLP-1Rs in beta and delta cells